# A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults

> **NCT06994897** · PHASE1 · RECRUITING · sponsor: **Pfizer** · enrollment: 92 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-07985631
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06994897
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-13
- **Primary completion:** 2027-12-08
- **Final completion:** 2027-12-08
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06994897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06994897, "A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06994897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*